Tool Calling and Plugins for Hematologic Oncology Products

Hematologic oncology data originates from diverse sources, including clinical trial reports, gene sequencing data, pathology diagnostic reports, drug

Data Characteristics in this Category

Hematologic oncology data originates from diverse sources, including clinical trial reports, gene sequencing data, pathology diagnostic reports, drug research and development literature, and regulatory approval documents. This data updates frequently, especially clinical trial progress and drug indication expansions, which can change weekly or even daily. Document structures vary, encompassing unstructured scientific papers, semi-structured clinical reports (such as patient records in PDF or DOCX format), and structured database records (like gene mutation libraries, drug target information). Fields and units are highly specialized, for example, gene mutation sites (e.g., FLT3-ITD), drug dosages (e.g., mg/kg), response rates (e.g., CR for complete remission), and specific biomarker expression levels (e.g., CD34+ cell percentage).

Constraints Imposed by these Characteristics on Tool Calling and Plugins

The highly specialized and diverse nature of hematologic oncology data requires tool calling and plugins to possess robust semantic understanding and multimodal processing capabilities. Extracting key information from unstructured clinical reports depends on precise entity recognition and relationship extraction, such as identifying tumor type, grading, and gene mutation status from pathology reports. High-frequency data updates, like clinical trial results, necessitate plugins that can regularly access external databases or APIs and synchronize the latest information promptly. Calling structured databases requires plugins to accurately construct query statements and handle complex query logic. Furthermore, correctly parsing many specialized terms and abbreviations places higher demands on the model's context window and the integration of domain-specific dictionaries to avoid ambiguity or misinterpretation.

Configuration Guidelines

Configuration ItemRecommended ValueRationale
maxContext8192Hematologic oncology reports often contain extensive details. This ensures complete context and prevents information truncation.
Chunk size (Segment Length)500–700 characters (characters)Balances semantic completeness with recall efficiency, avoiding noise from overly long segments.
Similarity threshold (Similarity Threshold)0.75Increases matching precision, reducing irrelevant or overly generalized results, especially for specialized terminology.
Recall count (Recall Count)Top 8–12 entries (top 8–12 entries)Provides sufficient candidate information for the model's comprehensive judgment, covering potential relevance.
PARSE_FILE_TIMEOUT_SECONDS600 seconds (seconds)Allows ample parsing time when processing large clinical trial reports or gene sequencing files.
MAX_HTTP_RETRIES3 times (times)External API calls are subject to network fluctuations; this adds a retry mechanism for improved stability.

Three Common Pitfalls

  • Calling an external database to query the latest indications for hematologic oncology drugs returns an empty result. This often occurs because the disease_code or drug_name parameters required by the API interface are incorrectly formatted, failing to match the standard fields in the database.
  • After uploading an XLSX format gene sequencing data file, the AI cannot conduct effective dialogue or analysis. This may be due to the file content being too large or the format being complex, causing PARSE_FILE_TIMEOUT_SECONDS to time out, and the file not being fully parsed and vectorized.
  • A workflow repeatedly calling an HTTP interface to retrieve multi-center clinical trial data encounters a 429 Too Many Requests error. This happens when an appropriate request interval is not set or the API's rate limits are not handled.

How to Verify Configuration

  • Upload a PDF document containing common hematologic oncology drugs, gene mutations, and clinical indicators. Verify that the AI correctly identifies and extracts key information, such as FLT3-ITD mutation status and Venetoclax drug dosage.
  • Test the tool calling function by querying a simulated clinical trial database for the latest drug research progress related to AML (Acute Myeloid Leukemia). Confirm that expected results are returned and that the NCT number (Clinical Trial Registry number) in the results is correct.
  • Execute a workflow involving multiple API calls, for example, first querying a patient's gene test report, then calling a drug recommendation interface based on the report results. Confirm that the entire process runs without errors and that the final recommended drugs are logically consistent with the report content.

The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.